yea.. the analysts havent updated their eps since the drug was approved... so you are looking at old information to make a poor decision How many analysts are covering ZYNX? Oh.. right.. zero zero institutions own it zero analysts cover it zero mutual funds own it the best you can hope for is to sell it to some other individual investor before the hot potato cools off fundamentals dont drive stocks... what people are willing to pay for them does... individual investors are easily manipulated... be careful POZN is UP... ZYNX is DOWN.. expect the trend to continue